Trade TVRD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Tvardi Therapeutics, Inc. (TVRD) is trading at US$1.80, up 1.12% today as of Aug 27, 16:00 EDT. The company has a market capitalisation of US$24.81M. Over the past 52 weeks, TVRD has traded between US$1.50 and US$43.65. On Syfe you can trade TVRD with $0 commission and add it to your watchlist.
| Previous close | US$1.78 |
|---|---|
| Market cap | US$24.81M |
| 52-week range | US$1.50 – US$43.65 |
| Volume | 70.4K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
Year: 2025
Piper Sandler Upgrades Tvardi Therapeutics to Overweight From Neutral, Adjusts Price Target to $13 From $3
Jul 9, 11:35 AM · MT Newswires
Tvardi Therapeutics Shares Rise After Raymond James Upgrade
Jul 8, 6:55 PM · MT Newswires
Sector Update: Healthcare Stocks Lower Wednesday Afternoon
Jul 8, 5:48 PM · MT Newswires
Top Midday Gainers
Jul 8, 5:26 PM · MT Newswires
Raymond James Upgrades Tvardi Therapeutics to Outperform From Market Perform
Jul 8, 11:27 AM · MT Newswires
Tvardi Therapeutics, Inc. (TVRD) stock is trading at US$1.80, +1.12% from the previous close of US$1.78.
The market cap for Tvardi Therapeutics, Inc. (TVRD) stock is approximately US$24.81M.
The 52-week high for Tvardi Therapeutics, Inc. (TVRD) stock is US$43.65.
The 52-week low for Tvardi Therapeutics, Inc. (TVRD) stock is US$1.50.
Tvardi Therapeutics, Inc. (TVRD) does not currently pay a dividend.
Stay on top of TVRD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
